Stroke causes approximately 1 in every 20 deaths in the United States. Most strokes are ischemic, 35 caused by a blockage of blood flow to the brain. While neurologists agree on the delineation of ischemic 36 stroke (IS) into the three most common subtypes (cardioembolic stroke (CES), large artery stroke 37
sample size while the intersect may yield a phenotype with less potential misclassification. 48
49
We performed GWAS for all subtypes, using the original subtyping systems, the intersect, and the union 50 as phenotypes. In each subtype, heritability was higher for the intersect phenotype compared to the 51 union, CCS (alone), and TOAST (alone) phenotypes. We observed stronger effects at known IS variants 52 with the intersect compared to the other phenotype definitions. In GWAS of the intersect, we identify 53 rs10029218 as an associated variant with small vessel stroke. We conclude that in the absence of a 54 golden standard for phenotyping, taking this alternate approach yields more power to detect genetic 55 associations in ischemic stroke.
Introduction 73
Stroke is one of the primary causes of death worldwide and causes ~1 in every 20 deaths in the United 74
States [1] . Eighty-seven percent of all strokes are ischemic, caused by a blockage of blood flow to the 75 brain [1] . Ischemic stroke (IS) tends to affect those older than 65 years old and has several known risk 76 factors, including type 2 diabetes, hypertension, and smoking. However, the affected population is 77 extremely heterogeneous in terms of age, sex, ancestral background, and socioeconomic status. 78 79 Ischemic strokes themselves are also heterogeneous in terms of clinical features and presumed 80 mechanism. The majority of IS are typically grouped into three subtypes: cardioembolic stroke (CES), 81 typically occurring in people with atrial fibrillation; large artery stroke (LAS), caused by eroded or 82 ruptured atherosclerotic plaques in arteries; and small vessel stroke (SVS), caused by a blockage of one 83 of the small vessels in the brain. These subtypes also seem to be genetically distinct: genome-wide 84 association studies (GWAS) in ischemic stroke have identified single-nucleotide polymorphisms 85 (SNPs) that primarily associate with a specific IS subtype [2] . To date, GWAS have identified 20 loci 86 associated with ischemic stroke, of which 9 appear to be specific to an IS subtype [2] . Furthermore, the 87 subtypes also have varying SNP-based heritabilities (estimated at 16%, 12% and 18% for CES, LAS 88 and SVS respectively [3] ), indicating that the phenotypic variation captured by genetic factors varies 89 across the subtypes. Improved genetic discovery can help further elucidate the underlying biology of 90 ischemic stroke as well as potentially help identify genetically high-risk patients who could be 91 candidates for earlier clinical interventions. 92 93 While neurologists and researchers agree on the delineation of ischemic stroke into these three primary 94 categories (CES, LAS and SVS), several subtyping systems are currently used to assign a subtype to an 95 ischemic stroke patient. The most commonly used approach is a questionnaire based on clinical 96 knowledge that was originally developed for the Trial of Org 10172 in Acute Stroke Treatment 97 (TOAST) [4] . TOAST was designed for implementation in the clinic and has also been used as 98 subtyping system in the majority of stroke GWAS. More recently, researchers have developed a second 99 subtyping system: the Causative Classification System for Stroke (CCS) [5], a decision model based on 100 clinical knowledge that also incorporates imaging data. There are two outputs of CCS: CCS Causative 101 (CCSc), which assigns one subtype to each patient based on the presumed cause of the stroke; and CCS 102 phenotypic (CCSp), which allows for multiple subtype assignments and incorporates the confidence of 103 the assignment. Previous work indicates that TOAST and CCS have moderate, but not high, 104
concordance in assigning subtypes in patients: agreement is lowest in SVS (κ = 0.56) and highest in 105 LAS (κ = 0.71) [6] . Notably, both subtyping systems still place more than one third of all samples into 106 a heterogeneous 'undetermined' category.
[6] 107 108 Determining a patient's subtype is difficult and prone to misclassification [7] , but critical to genetic 109 discovery in ischemic stroke, as demonstrated by the prevalence of subtype-specific association signals. 110
If a group of cases is comprised of phenotypically heterogeneous samples with different underlying 111 genetic risk, power to detect a statistically significant association at a truly associated SNP is reduced 112 (Fig 1) . In contrast, a case definition that captures a more phenotypically homogenous group of cases 113 would improve the chances of detecting genetic variants that associate with disease. Therefore, we used 114 the TOAST, CCSc and CCSp subtype assignments to define two new phenotypes per subtype: the 115 intersect, for which an individual must be assigned the same subtype across all three subtyping systems; 116 and the union, for which an individual must be assigned that subtype by at least one of the subtyping 117 systems. Analyzing the union potentially improves power for locus discovery due to its larger sample 118 size, but at the cost of more potential misclassification. In contrast, analyzing the intersect may improve 119 power for genetic discovery by generating a phenotype that is less prone to mis-classification, despite 120 a smaller sample size. 121
122
Here, we perform GWAS with the union and intersect phenotypes for each primary IS subtype to 123 investigate whether these newly-defined phenotypes indeed improve our ability to detect genetic risk 124 factors for ischemic stroke. We find heritability estimates to be highest in the intersect phenotype for 125 all subtypes. We also find stronger effects at known associations for the intersect compared to the union, 126 and we validate a previously suspected association in small vessel stroke through GWAS of the 127 intersect phenotype. 128 indicate the protective allele, and crosses the risk allele. Using a chi-square test (visualized with contingency 131 tables), the measured effect is stronger with a group of cases that is more homogeneous but smaller (intersect, 132 purple) than with a group of cases that is less strictly defined but is larger (union, teal).
133
Results 135 136 Genome-wide association study data processing 137
To investigate how redefining stroke phenotypes improves our ability to detect SNPs associated with 138 ischemic stroke, we employed the SiGN dataset. Data processing of the SiGN dataset, including quality 139 control and imputation, has been described in detail elsewhere [8] . Briefly, the dataset includes 13,930 140 IS cases and 28,026 controls of primarily European descent. Cases and controls were genotyped 141 separately (with the exception of a small number of cohorts) and on various Illumina arrays and then 142 merged together into case-control groups matched for genotyping array and sample ancestry (via 143 principal component analysis). For the cases, phenotype definitions based on one or more of the CCSc, 144
CCSp and TOAST subtyping systems are available ( Table 1) . 145
146
We began our analyses by running genome-wide association studies for all phenotype definitions, 147
including our intersect and union definitions, in all subtypes. We ran all GWAS using a linear mixed 148 model implemented in BOLT-LMM (Supplemental Figure 2) [9]. To take into account any residual 149 population stratification and other batch effects, we included the first 10 principal components and sex 150 as covariates in these analyses (Table S2) . 151
152
Because the intersect by definition is contained in the union, one additional GWAS for each subtype 153 was run to enable a truly independent comparison of intersect with the symmetric difference (the union 154 minus the intersect). This study focuses on the balance in statistical power between a high sample size 155 and more strictly defined phenotype. Therefore, this sensitivity analysis was only done for the 156 comparison between the two most extreme case definitions. 157 The control group is always the same group of 28,026 individuals 160 161
Genetic variance in a strictly defined case group explains a higher proportion of phenotypic variance 162
To estimate how much of the variation in a particular phenotype can be explained by genetic variation, 163
we calculated the heritability (h 2 ) of each phenotype using BOLT-REML, assuming an additive model 164 of effect sizes over all SNPs. We estimated heritability in each of the available phenotypes: the subtypes 165 as defined by TOAST, CCSc, CCSp, the union, and the intersect. We found that the intersect yields a 166 higher h 2 estimate than the union in all ischemic stroke subtypes (Fig 2, Table S3 ). For instance, in CES, 167 h2 of union is 0.139 ± 0.009 and h2 of intersect is 0.275 ± 0.017. We additionally found that the second 168 highest heritability in large artery and small vessel stroke was in CCSc (h2-LAS = 0.258 ± 0.023 and 169 h2-SVS = 0.315 ± 0.029), which assigns only one subtype to each case. The heritabilities for CCSc, 170
CCSp and TOAST were not significantly different from one another in cardioembolic stroke ( Table  171 S4), indicating that each original subtyping system is capturing approximately the same proportion of 172 genetic risk. between intersect and all others except CCSc, 2.7e-03 or lower in LAS, 6.1e-07 or lower in SVS). P-values for 181 heritability differences determined by t-test (see Table S5 ). See Table S4 for numerical values of heritabilities and 182 standard errors.
184

Different phenotype definitions represent genetically distinct phenotypes 185
While heritability gives an estimation of how much variation in a phenotype can be attributed to genetic 186 factors, it does not show how different two phenotypes are from one another (i.e., two phenotypes can 187 have the same heritability and yet be genetically distinct from each other). We therefore evaluated the 188 overlap in significant SNPs for all pairwise combinations of phenotypes for which we performed a 189 GWAS, where high proportions of shared SNPs between two phenotypes indicate genetic similarity. At 190 multiple significance cutoffs, we assessed overlap of significant SNP sets using two complementary 191 similarity measures: the Jaccard index, which measures the ratio of overlapping SNPs (those are 192 significant in both analyses) in the total set of SNPs that are significant in either analysis; and the 193 Pearson correlation of the z-scores of the overlapping SNPs in both analyses (Fig 3) . Significance is 194 defined here as an absolute z-score that is higher than the selected z-score threshold (where SNPs can 195 have an effect size < -Z or > +Z). A high Jaccard index indicates that two phenotypes share many of 
205
We also calculate the Pearson correlation of the z-scores of the shared SNPs.
207
In order to assess the results of the overlap analyses and their meaning with respect to the ischemic 208 stroke phenotypes, we also performed these analyses between the phenotype definitions and an 209 unrelated GWAS of educational attainment to obtain a null reference ( Fig S3) . 210
211
In cardioembolic stroke (Fig 4, first panel) , the Jaccard index for all combinations with intersect 212 decreases with more extreme z-scores to J≈0.2-0.3 while the correlation increases quickly to approach 213 r 2 =1 at Z≈2.5, indicating that a relatively small group of SNPs is significant in both analyses with 214 correlating z-scores, that gets increasingly smaller and stronger correlating. These findings indicate that 215 the stricter the significance threshold is, the fewer shared SNPs there are between any two phenotypes, 216 but that those shared SNPs have more concordant effect sizes. In large artery stroke ( Fig S4) and small 217 vessel stroke ( Fig S5) the trend is similar, albeit with lower Jaccard indices and correlations, suggesting 218 that there is a set of associated SNPs for each subtype that is found by all phenotype definitions. In all 219 subtypes, when compared to symmetric difference, the intersect is the most genetically distinct 220
phenotype. This confirms that if we combine symmetric difference and intersect, as in the union, we 221 increase phenotypic heterogeneity and thereby decrease the likelihood of detecting a genome-wide 222 significant signal. in all analyses, we also calculated overall Jaccard index: the size of the intersect of SNPs that are 233 significant in all 5 phenotypes (excluding symmetric difference, which we use for sensitivity testing 234 only), divided by the size of their union. The overall Jaccard index ( Fig 5) confirms what was suggested 235 by the pairwise overlap analyses: there is a small set of SNPs that is shared across all phenotype 236 definitions, albeit slightly smaller than the pairwise overlapping sets. The Jaccard index is relatively 237 low at higher significance thresholds, indicating that there is also a substantial set of SNPs that is unique 238 to each phenotype definition. Thus, we do find different associated SNPs to ischemic stroke subtypes 239 depending on how exactly the subtype status is defined, but there are some concordant SNPs that are 240 found by all case definitions, regardless of sample size or phenotype homogeneity. 
247
Intersect shows the largest effect at previously known associations 248
A recent GWAS (MEGASTROKE) in 67,162 TOAST-subtyped cases and 454,450 controls identified 249 32 loci (22 novel) associated to stroke (either ischemic stroke or intracerebral hemorrhage) and its 250 subtypes [2] . Four of the 32 loci associate to CES, five to LAS, and none to SVS. We investigated the 251 potential to find stroke-associated loci in our redefined phenotypes, with a sample that is 4 to 7 times 252 smaller than MEGASTROKE. To this end, we compared the odds ratios for the 9 known subtype-253 specific loci in our five phenotype definitions, see Fig 6. In cardioembolic stroke, the intersect 254 phenotype consistently shows the strongest effect. In large artery stroke, intersect shows the strongest 255 effect as well, except at the LINC01492 locus. 256
257
Besides comparing the ORs at subtype-specific signals, we also compared ORs at all stroke-associated 258 loci (including any stroke, any ischemic stroke, cardioembolic stroke and large artery stroke), see Fig  259   S1 . We found that intersect shows the strongest odds ratio 30 times out of 96, (binomial p = 0.010), 260
indicating that odds ratios derived from the intersect phenotype are indeed stronger than the ORs in the 261 other phenotypes more often than expected by chance. Our analyses revealed 5 new loci (2 for SVS and 3 for CES, Figure S5 ), was found in the intersect 287 analysis, and replicated in the trans-ancestry analysis of MEGASTROKE. The other SVS associated 288 variant (rs11065979) in the SH2B3-BRAP-ALDH2 locus was found in the CCSp analysis, and replicated 289 in both the trans-ancestry analysis and the European analysis (Table 2, Figure S5 ). For the 3 CES loci, 290 only one variant (rs3790099, in the GNAO1 gene, found in the CCSp analysis) was replicated in the 291
Europeans-only analysis (Table 2, Figure S5 ). In a meta-analysis of a) the MEGASTROKE GWAS 292 without the SiGN cohort and b) the SiGN GWAS for these three SNPs, we found consistent direction 293 of effect in both studies and a lower p-value (Table S5) . 294 295 Previously, one other locus was reported to associate solely with SVS (16q24 [11] ). Here, by applying 296
an alternate phenotyping approach, we identify 4p12 as a novel SVS locus. In general, despite the low 297 sample size as compared to MEGASTROKE, we find stronger associations in the intersect GWAS, 298 likely due to the clearer separation of cases and controls.
Discussion 300
To help uncover genetic associations with ischemic stroke that as yet have gone undetected, we defined 301 new ischemic stroke phenotypes based on three existing subtyping systems (CCSc, CCSp, and TOAST) . 302
Specifically, we studied the intersect and union of these subtyping systems, for all ischemic stroke 303 subtypes. The intersect results in a smaller number of available cases but potentially results in less 304 misclassification due to agreement between subtyping systems. The union is potentially more 305 heterogeneous, but results in a larger available group of cases. We find that the largest proportion of 306 phenotypic variance explained by SNPs is in the intersect phenotype. Further, our overlap analyses 307
show that, for each subtype, the phenotype definitions each have a unique set of significantly associated 308
SNPs, but that there is also a small set of SNPs that is shared among all definitions, with concordant 309 direction of effect and similar trend in magnitude of effect. We also show that the cases that are in the 310 union but not in the intersect, are genetically distinct from the intersect-cases, implying that the union 311 is a combination of phenotypically heterogeneous cases. With an effective sample size that is 4 to 7 312 times as small as in MEGASTROKE, we find stronger associations (i.e., higher ORs and lower p-313 values) at known loci by using the intersect (compared to the other phenotype definitions studied here). 314
This indicates that the intersect yields more net power to detect associations due to its stricter definition, 315 despite its lower sample size, and is thus better suited as a phenotype in GWAS. 316
317
We identify a previously sub-threshold association with a SNP in an intron of the CAMK2D locus in 318 small vessel stroke by using the intersect, further demonstrating the utility of this phenotype in GWAS. 319 CAMK2D expresses a calcium/calmodulin-dependent protein kinase [12] ; out of all tissues tested in 320
GTEx, the two tissues with the highest expression are both in brain [13] . The CAMK2D locus was found 321 to also associate with P-wave [14] , an electrocardiographic property that is implicated in atrial 322 fibrillation, a trait that is associated with cardioembolic stroke [3] . Given that the association replicates 323 in an independent dataset, and the protein is expressed in brain, further fine-mapping in this region may 324
give more insight into the biological mechanisms that contribute to stroke. Additionally, we find the 325 SH2B3 -BRAP -ALDH2 locus to be associated with small vessel stroke. rs11065979 is an eQTL of 326 ALDH2 (aldehyde dehydrogenase 2) [13] . ALDH2 is involved in ethanol metabolism; it converts one of the products, ethanal, into acetic acid. The allele that is associated with higher expression of this 328 enzyme is associated with lower incidence of small vessel stroke. ALDH2 is mainly expressed in liver, 329 but it is also expressed in brain. [13] Previous work has shown an association between higher expression 330 of ALDH2 and lower incidence of stroke in rats [15] . SH2B3 and BRAP are minimally expressed in 331
brain, compared to the other tissues [13] . We also show an association between the GNAO1 locus and 332 cardioembolic stroke. The protein product of this locus constitutes the alpha subunit of the Go 333 heterotrimeric G-protein signal-transducing complex [12] . It is highly expressed in brain, and while its 334 function is not completely clear, defects in the protein are associated with brain abnormalities [16] . 335
Although this alternate approach to phenotyping has resulted in new associations with two ischemic 336 stroke subtypes, the causality of these loci remains uncertain and warrants further study. 337
338
Phenotype definition is an oft-encountered issue in complex trait genetics, as diagnosing and subtyping 339 methodologies can vary and even be contentious within disease areas. Further, phenotype labels are 340 often broad definitions for cases that can be highly heterogeneous when their underlying genetic risk is 341 examined. For example, most psychiatric diseases are also complex and phenotypically heterogeneous, 342 lacking clear and robust diagnostic criteria. In an editorial, the Cross-Disorder Phenotype Group of the 343 Psychiatric GWAS Consortium states: "We anticipate that genetic findings will not map cleanly onto 344 current diagnostic categories and that genetic associations may point to more useful and valid 345 nosological entities". Our findings here further support this statement, showing that while the original 346 subtyping systems might be useful for diagnosing individual patients, alternative phenotyping 347 approaches and criteria are needed for future genetic studies aimed at unraveling the underlying biology 348 of disease. work, we use the same 28,026 controls from this previous GWAS, as well as the 13,930 ischemic stroke 360 cases of European and African ancestry. A third group of cases and controls, primarily comprised of 361 individuals who identify as Hispanic and residing in the United States, has been excluded due to data 362 sharing restrictions. All data processing has been previously described.
[18] All genotyping data was 363 generated using human genome build hg19. 364
365
Genome-wide association studies in We ran all GWAS in BOLT-LMM [9] , which implements a linear mixed model (LMM). BOLT-LMM 367 implements a Leave-One-Chromosome-Out (LOCO) scheme, so that the genetic relationship matrix 368 (GRM) is built on all chromosomes except the chromosome of the variant being tested. Linear mixed 369 models have been demonstrated to improve power in GWAS while correcting for structure in the data 370
[20]. In addition to the GRM, we included the first 10 principal components as fixed effects. We used 371 the following approximation to convert the effect estimates from BOLT-LMM (on the observed scale) 372 to effect estimates on the liability scale: log( ) = ( * (1 − )) / where is the case fraction.
[21] 373
For each subtype, the intersect, union and symmetric difference of the original subtyping systems were 374 used as phenotypes in separate GWAS. The original subtyping systems were also used as a phenotype 375 in three additional GWAS per subtype to serve as a point of reference. All ischemic stroke cases that 376 do not belong to the case definition under study were left out of the analysis. The same group of controls 377 is used in all analyses. Association testing was done on all imputed SNPs with a minimum minor allele 378 frequency of 1%. See Supplementary Table 8 in [22] for simulations of type 1 error inflation of BOLT-379 LMM in datasets with unbalanced case-control ratios. In the GWAS discussed here, case fractions range 380 from 0.05 to 0.14 which means that at variants with MAF >1%, there is no significant inflation of type 381 1 error rates. Those SNPs that show a large frequency difference (>15%) across the populations in 1000 382
Genomes were removed (see the methods in [18] for details on how this list of SNPs was compiled). and Manhattan-plots. The genomic inflation factor (lambda) varies between 1.0 and 1.1 for 385 cardioembolic stroke and large artery stroke, and between 1.0 and 1.2 for small vessel stroke. We 386 observed a relatively high inflation factor of 1.2 in only the imputed SNPs with a minor allele frequency 387 lower than 5%. Therefore, summary statistics for these SNPs were removed from downstream analyses. 388 389
Heritability estimation in BOLT-REML 390
To estimate the heritability of the six phenotype definitions for each subtype, we used BOLT-REML 391
[23]. BOLT-REML calculates heritability from the SNPs included in the GRM, and these SNPs must 392 be genotyped (and not imputation dosages). We therefore based our estimates on only genotyped SNPs. 393 Furthermore, we excluded the MHC on chromosome 6, and chromosomal inversions on chromosomes 394 8 and 17 using PLINK 1.9 [24] . See Table 3 for more information. We filtered on various quality control 395 measures, by passing the following flags to PLINK: --mind 0.05 --maf 0.10 --geno 0.01 --hwe 0.001. 396
Additionally we pruned SNPs at an LD (r 2 ) threshold of 0.2 (--indep-pairwise 100 50 0.2). We used the 397 first 10 principal components and sex (determined by presence of XX or XY chromosomes) as 398 covariates. To convert the heritabilities from the observed scale (as if the binary data, coded as 0-1, 399
were continuous) to the liability scale (converting the heritabilities of the observed binary trait to the 400 heritabilities of the underlying, unobserved, continuous liability of the trait), Dempster et al derived a 401 formula that takes into account the prevalence of the disease in the population [25] . In the case of 402 ascertained case-control traits, where the population prevalence is not equal to the study prevalence, 403 this has to be taken into account as well [26]: Where ℎ 1 2 3 is the heritability on the liability scale, K is the population prevalence, P is the study 406 prevalence, t is the liability threshold, and ℎ 1 8 3 is the heritability on the observed scale. To test for 407 significant difference between the estimated heritabilities, we performed an independent t-test. 408 409 
Overlap analysis 412
We first calculated z-scores using the following formula: z = beta / se, where beta is the effect size of 413 the SNP and se is the standard error of the beta estimate. The z-scores thus have unit standard error, but 414 we did not standardize them to zero mean (as is the conventional method for calculating z-scores) to 415 maintain the original direction of effect. To assess overlap between two GWAS, we calculated the 416 Jaccard index [27] , which is the ratio of a) the number of SNPs significant in both analyses, to b) the 417 number of SNPs significant in either analysis (i.e., the size of the intersect divided by the size of the 418 union of the sets of significant SNPs). The index is a number between 0 and 1: it is 0 if the two sets of 419 significant SNPs do not have any SNPs in common, and it is 1 if the two sets of significant SNPs 420 completely overlap. We additionally calculated, within the set of SNPs that are significant in both 421 analyses, the Pearson's correlation of the z-scores in the two GWAS to check the concordance of 422 direction and size of effect in the two analyses being compared. Significance was defined as a z-score 423 that is more extreme than an absolute z-score threshold z (varied from 0 until 3, in increments of 0.1). 424
At the most extreme z-score threshold (z >3 or z < -3), the absolute number of SNPs that are significant 425 in both analyses is indicated in the plot. As a null comparator, these overlap analyses were also
